Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02665182
Other study ID # SP12-1
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date July 2012
Est. completion date January 2021

Study information

Verified date December 2018
Source Medical University of Warsaw
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-blinded RCT evaluating the value of up-positioning of the testes as supportive therapy in patients receiving antimicrobial treatment due to acute bacterial orchitis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 70
Est. completion date January 2021
Est. primary completion date January 2020
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- acute orchitis confirmed clinically and in scrotal ultrasound

- age >=18 yrs

Exclusion Criteria:

- previous treatment of orchitis,

- need for exploration of the scrotum,

- need for hospitalization,

- physical and mental status not allowing for up-positioning of the testes during treatment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Up-positioning of the testes
Patients in the experimental arm are asked to elevate their testes during the treatment.

Locations

Country Name City State
Poland Slawomir Poletajew Warsaw

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Warsaw

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to alleviation of symptoms 10 days
Primary Time to clinical resolution of local symptoms 10 days
Secondary Testicular pain 10 days
Secondary Testicular swelling 10 days
Secondary Testicular erythema 10 days
Secondary Scrotal pain intensity 10 days
Secondary Quality of life 10 days
Secondary Body temperature 10 days
Secondary Heart rate 10 days
Secondary Duration of up-positioning of testes per day 10 days
See also
  Status Clinical Trial Phase
Completed NCT03403777 - Avelumab in Refractory Testicular Germ Cell Cancer. Phase 2
Enrolling by invitation NCT05617261 - Evaluating Patient Tolerability and Success for Penile and Scrotal Urologic Procedures Under Conscious Sedation: A Prospective Study
Completed NCT05146466 - Enhancing Men's Awareness of Testicular Diseases (E-MAT): A Feasibility Trial N/A
Active, not recruiting NCT03426865 - Role of Axumin PET Scan in Germ Cell Tumor
Recruiting NCT03056027 - Testicular Vascular Evaluation in Patients Undergoing Inguinal Hernia Repair N/A
Completed NCT00012480 - Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm N/A